Ischemic Stroke
Ischemic stroke occurs when a blood clot blocks blood flow to the brain, leading to brain cell damage. It can cause sudden symptoms like weakness, confusion, and difficulty speaking.
Ghrelin for Acute Ischemic Stroke Treatment
We are studying whether ghrelin can improve recovery in patients with acute ischemic stroke treated with endovascular thrombectomy. The trial will also assess its effects on overall health and safety over several days.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Have you had a stroke caused by a blockage in the blood vessels of the brain?
- Do you have a disability that affects your daily life (mRS score of 2 or higher)?
- Is your life expectancy less than one year?
- Are you currently pregnant or breastfeeding?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Acyl-Ghreline
Lenomorelin
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Rijnstate Ziekenhuis Stichting
Neurology
Arnhem, Netherlands
Universitair Medisch Centrum Utrecht
Neurology
De Bilt, Netherlands
Medisch Spectrum Twente
Neurology
Enschede, Netherlands
Sponsor: Rijnstate Ziekenhuis Stichting
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.